Brief: XBiotech Candidate True Human COVID-19 Therapy Found To Target Highly Infectious Emerging Strain
21/01/2021 14:39
Jan 21 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH CANDIDATE TRUE HUMAN™ COVID-19 THERAPY FOUND TO
TARGET
HIGHLY INFECTIOUS EMERGING STRAIN
* XBIOTECH INC - COVID-19 CANDIDATE TRUE HUMAN™ ANTIBODY
THERAPY
MAY ALSO BE USED FOR TREATING COVID-19 MUTANT VIRUS THAT
RECENTLY EMERGED IN UK
Source text for Eikon: ID:nGNX7R1W6t
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke